GLP1R-imaging in Post-RYGB Hypoglycemia
Visualizing Beta Cells in Patients With Hyperinsulinemic Hypoglycemia After Bariatric Surgery
Rijnstate Hospital
24 participants
Nov 1, 2016
INTERVENTIONAL
Conditions
Summary
In order to evaluate the difference in beta cell mass in patients with and without hyperinsulinemic hypoglycemia after Roux en Y gastric bypass (RYGB) investigators aim to compare quantitative PET imaging of the pancreas between these patient groups. These highly relevant data will provide investigators with more information on the possible role of beta cell mass in the mechanisms of hyperinsulinemic hypoglycemia bariatric surgery.
Eligibility
Inclusion Criteria9
- Signed informed consent
- Patients:
- \- Persisting hyperinsulinemic hypoglycemia after a low-carbohydrate diet and/or insulin suppressive medication for one year.
- Controls:
- RYGB at least 2 years ago
- Normal glucose levels before and after RYGB (fasting glucose between 4 and 6 mmol/l or HbA1c between 20 and 42 mmol/mol)
- Score ≤ 7 on Sigstad's scoring system (Table 1)
- Hypoglycemia excluded by 14-day continuous glucose monitoring
- Individual matched to HH group on age (± 5 years), sex and BMI at time of inclusion (± 2 kg/m2)
Exclusion Criteria8
- Anti-diabetic medication in the past 6 months
- Treatment with synthetic Exendin (Exenatide, Byetta®) or Dipeptidyl-Peptidase IV inhibitors in the past six months.
- Known liver failure or serum liver values over 2 times normal value at the time of standard laboratory assessment. Normal values of total bilirubin, γ-GT, ASAT and albumin are \<21 μmol, \<40 U/l, \<30 U/l and 35-50 g/l respectively
- Pregnancy or the wish to become pregnant within 6 months
- Breast feeding
- Kidney failure, i.e. calculated creatinine clearance below 40 ml/min
- Age \< 18 years
- No signed informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Beta cell function (tests) and measure for beta cell mass (PET)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05597475